CAPR - Capricor Therapeutics slumps 25% prices $23M equity
2023-09-29 09:06:05 ET
More on Capricor Therapeutics
- Capricor: Q4 2023 Interim Analysis For DMD Treatment Makes This A Must Watch
- Seeking Alpha’s Quant Rating on Capricor Therapeutics
- Historical earnings data for Capricor Therapeutics
For further details see:
Capricor Therapeutics slumps 25%, prices $23M equity